Madrigal Pharmaceuticals, Inc. MDGL Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Madrigal Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s earnings yield?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported earnings yield of -2.6% in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s earnings yield changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s earnings yield increased by 51.9% year-over-year, from -5.4% to -2.6%.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s earnings yield?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s earnings yield has grown at a -27.2% compound annual growth rate (CAGR), from -10.6% to -2.2%.
- What does earnings yield mean?
- The company's annual profit as a percentage of its market price — the flip side of the P/E.
- How do you interpret earnings yield?
- Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
- How does earnings yield compare across companies?
- Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.